As the opioid crisis in the United States has mounted, pharmaceutical manufacturers have been hit with lawsuits claiming that they used deceptive marketing tools to push the drugs to doctors and failed to advise patients about prospective risks. Now, the once seemingly infallible pharmaceutical companies are beginning to show signs …
Read More »Opioid Crisis: FDA Clears Life-Saving Drug for Over-the-Counter Sales
On Thursday, January 17th, the Food and Drug Administration (FDA) announced it was taking unprecedented steps to encourage drug companies to develop over-the-counter (OTC) versions of the overdose antidote naloxone in an effort to increase access and cut costs for consumers in hopes of reducing opioid deaths. “FDA-approved versions of …
Read More »